Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Change in Account Payables (2020 - 2025)

PROCEPT BioRobotics has reported Change in Account Payables over the past 6 years, most recently at $5.9 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $5.9 million for Q4 2025, up 210.3% from a year ago — trailing twelve months through Dec 2025 was $6.6 million (up 408.92% YoY), and the annual figure for FY2025 was $6.6 million, up 408.92%.
  • Change in Account Payables for Q4 2025 was $5.9 million at PROCEPT BioRobotics, up from -$789000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for PRCT hit a ceiling of $5.9 million in Q4 2025 and a floor of -$5.4 million in Q4 2024.
  • Median Change in Account Payables over the past 5 years was $396000.0 (2022), compared with a mean of $752800.0.
  • Biggest five-year swings in Change in Account Payables: plummeted 2819.3% in 2021 and later skyrocketed 3722.22% in 2024.
  • PROCEPT BioRobotics' Change in Account Payables stood at -$1.5 million in 2021, then surged by 81.68% to -$284000.0 in 2022, then surged by 2169.01% to $5.9 million in 2023, then crashed by 191.54% to -$5.4 million in 2024, then soared by 210.3% to $5.9 million in 2025.
  • The last three reported values for Change in Account Payables were $5.9 million (Q4 2025), -$789000.0 (Q3 2025), and -$2.2 million (Q2 2025) per Business Quant data.